Literature DB >> 17644418

Age-at-onset in restless legs syndrome: a clinical and polysomnographic study.

S Whittom1, Y Dauvilliers, M-H Pennestri, F Vercauteren, N Molinari, D Petit, J Montplaisir.   

Abstract

OBJECTIVE: To determine the distribution of age-at-onset in a large cohort of patients with restless legs syndrome (RLS) and to compare clinical and polysomnographic characteristics of patients with early and late age-at-onset of RLS.
METHODS: Two hundred and fifty patients with RLS were studied. Information on age-at-onset, etiology, familial history and symptoms severity of RLS was obtained. Age-at-onset density functions were determined from bootstrap methods and kernel density estimators.
RESULTS: Age-at-onset showed a significant bimodal distribution with a large peak occurring at 20 years of age and a smaller peak in the mid-40s. Early- and late-onset RLS could be separated with a cut-off at 36 years of age. Distributions of age-at-onset differed as a function of presence/absence of a familial history and etiology of RLS. Age-at-onset clearly differentiated patients with a primary RLS (early onset) from those with secondary RLS. Finally, early-onset RLS was associated with increased RLS severity with higher indices of periodic leg movements in sleep (PLMS) associated with microarousals and periodic leg movements during wakefulness (PLMW).
CONCLUSIONS: Early- and late-onset RLS could be distinguished depending on familial history and etiology of RLS. Our data suggest that different pathological processes are involved in these two groups, the early-onset group being highly genetically determined.

Entities:  

Mesh:

Year:  2007        PMID: 17644418     DOI: 10.1016/j.sleep.2007.01.017

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  10 in total

1.  Restless legs syndrome: relationship between prevalence and latitude.

Authors:  Brian B Koo
Journal:  Sleep Breath       Date:  2011-12-31       Impact factor: 2.816

2.  The Relationship of Restless Legs Syndrome to History of Pregnancy-Induced Hypertension.

Authors:  Kim E Innes; Sahiti Kandati; Kathryn L Flack; Parul Agarwal; Terry Kit Selfe
Journal:  J Womens Health (Larchmt)       Date:  2016-02-25       Impact factor: 2.681

3.  Defining the phenotype of restless legs syndrome/Willis-Ekbom disease (RLS/WED): a clinical and polysomnographic study.

Authors:  Fabrizio Rinaldi; Andrea Galbiati; Sara Marelli; Maria Cusmai; Alessandro Gasperi; Alessandro Oldani; Marco Zucconi; Alessandro Padovani; Luigi Ferini Strambi
Journal:  J Neurol       Date:  2016-01-02       Impact factor: 4.849

4.  Restless legs syndrome is frequent in narcolepsy with cataplexy patients.

Authors:  Giuseppe Plazzi; Raffaele Ferri; Elena Antelmi; Sophie Bayard; Christian Franceschini; Filomena I I Cosentino; Beatriz Abril; Karen Spruyt; Federica Provini; Pasquale Montagna; Yves Dauvilliers
Journal:  Sleep       Date:  2010-05       Impact factor: 5.849

Review 5.  Iron, dopamine, genetics, and hormones in the pathophysiology of restless legs syndrome.

Authors:  Farhan H Khan; Caitlyn D Ahlberg; Christopher A Chow; Divya R Shah; Brian B Koo
Journal:  J Neurol       Date:  2017-02-24       Impact factor: 4.849

6.  The Association of Restless Legs Syndrome to History of Gestational Diabetes in an Appalachian Primary Care Population.

Authors:  Kim E Innes; Sahiti Kandati; Kathryn L Flack; Parul Agarwal; Terry Kit Selfe
Journal:  J Clin Sleep Med       Date:  2015-10-15       Impact factor: 4.062

7.  Depth and Distribution of Symptoms in Restless Legs Syndrome/ Willis-Ekbom Disease.

Authors:  Paul Yeh; William G Ondo; Daniel L Picchietti; J Steven Poceta; Richard P Allen; Charles R Davies; Lily Wang; Yaping Shi; Kanika Bagai; Arthur S Walters
Journal:  J Clin Sleep Med       Date:  2016-12-15       Impact factor: 4.062

Review 8.  Use of α2δ Ligands for Restless Legs Syndrome/Willis Ekbom Disease.

Authors:  Michele A Faulkner
Journal:  CNS Drugs       Date:  2018-02       Impact factor: 5.749

9.  Restless legs syndrome is a relevant comorbidity in patients with inflammatory bowel disease.

Authors:  Janek Becker; Felix Berger; Katharina A Schindlbeck; Denis Poddubnyy; Peter M Koch; Jan C Preiß; Britta Siegmund; Frank Marzinzik; Jochen Maul
Journal:  Int J Colorectal Dis       Date:  2018-04-03       Impact factor: 2.571

10.  A Genome-Wide Association Study Identifies UTRN Gene Polymorphism for Restless Legs Syndrome in a Korean Population.

Authors:  Chul-Hyun Cho; Ji-Hye Choi; Seung-Gul Kang; Ho-Kyoung Yoon; Young-Min Park; Joung-Ho Moon; Ki-Young Jung; Jin-Kyu Han; Hong-Bum Shin; Hyun Ji Noh; Yong Seo Koo; Leen Kim; Hyun Goo Woo; Heon-Jeong Lee
Journal:  Psychiatry Investig       Date:  2017-11-07       Impact factor: 2.505

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.